Global Molecular Cytogenetic Market – Industry Trends and Forecast to 2030

Analyse et taille du marché de la cytogénétique moléculaire

Selon l'OMS, le cancer est l'une des principales causes de décès, avec 11,5 millions de décès dans le monde en 2030. Le cancer du poumon est l'une des principales causes de décès chez les hommes comme chez les femmes. Il existe actuellement de nombreux kits disponibles dans le commerce pour le diagnostic du cancer, le kit UroVysion d'Abbott Molecular pour le cancer de la vessie étant le seul disponible pour la détection précoce du cancer de la vessie. De même, les kits de détection disponibles dans le commerce comprennent PathVysion pour le cancer du sein, le kit de sonde Vysis CLL FISH pour les troubles hématologiques, et d'autres.

Data Bridge Market Research analyse que le marché de la cytogénétique moléculaire, qui était de 2,76 milliards USD en 2022, devrait atteindre 5,80 milliards USD d'ici 2030, à un TCAC de 9,7 % au cours de la période de prévision 2023 à 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché de la cytogénétique moléculaire  

Market Definition

Molecular cytogenetic combines molecular biology and cytogenetics. Cytogenetics is the study of chromosomes, and molecular cytogenetics is the analysis of genetic variations or alterations using in-situ hybridization techniques. Molecular cytogenetics has critical applications in biology and medicine. Molecular cytogenetics is the study of the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression and evolution, and chromosomal abnormalities, particularly in medicinal and cancer genetics. Techniques such as fluorescence in situ hybridization (FISH) are used in molecular cytogenetics to visualize the entire genome or specific regions of the genome.

Global Molecular Cytogenetic Market Dynamics

Drivers

• Increase in R&D Activities

The large number of research centres in China and India and R&D centres in Japan will increase demand for high-quality molecular cytogenetics. Japan is the leading contributor to the global molecular cytogenetics market, owing to long-standing collaborations between manufacturers and research institutions. Furthermore, personalized medicine's role in treating genetic or other disorders is gaining traction in developed countries, which is expected to boost the market during the forecast period.

• Increasing prevalence of cancer 

Cancer diagnostics primarily drives molecular cytogenetics, and it provides techniques for imaging in genetics, epigenetics, and cytology, as well as the ability to detect chromosomal changes. The rising prevalence of cancer and the resulting need for accurate diagnosis are expected to drive the global molecular cytogenetic market between 2023 and 2030.

Opportunities

• Technically advance healthcare sector

The rising government and private healthcare spending, and improved healthcare infrastructure in this region all contribute to the growth of the molecular cytogenetic market. For instance, a woman in the United States has a 13% chance of developing breast cancer in her lifetime. In 2018, an estimated 234,030 new cases of lung cancer were discovered, and 541,000 Americans have been diagnosed with the disease at some point in their lives. These findings demonstrate the enormous potential for growth and expansion in the molecular cytogenetic market.

Restraints/Challenges

• Lack of Skilled professional

Some factors, such as technical limitations and complexities associated with the equipment, are expected to impede the growth of the molecular cytogenetic market during the forecast period. However, the high cost of cytogenetic instruments and a lack of awareness about advanced technological methodologies, particularly in low and middle-income countries, are expected to hamper market growth during the forecast period.

This molecular cytogenetic market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the molecular cytogenetic market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Molecular Cytogenetic Market

COVID-19 is expected to have a significant impact on the market. Around the world, there have been several changes in consumer demand and behaviour, purchasing habits, and significant government initiatives. The COVID-19 has altered the population's nutrition, substance use and health-related behaviours. Furthermore, as COVID-19 spreads around the world, hospitalization rates are dropping dramatically. Several reports indicated that many hospitals were operating at less than 50% capacity in order to reduce noncritical medical services and elective surgeries. As a result, COVID-19 is expected to have a large impact on the molecular cytogenetic market.

Recent Developments

• In August 2022, Agilent Technologies Inc. announced the acquisition of Polymer Standards Service GmbH (PSS), a provider of polymer characterization solutions. PSS specializes in hardware and software solutions for defining molecular structure makeup and creation. The company offers complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC), which are used to determine the molecular weight and size distribution of macromolecules in applications.

Global Molecular Cytogenetic Market Scope

The molecular cytogenetic market is segmented on the basis of technique, product, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technique

• Fluorescence In Situ Hybridization
•  Comparative Genomic Hybridization
• Array-based comparative genomic hybridization
• Standard comparative genomic hybridization
•  In situ Hybridization
•  Karyotyping
• Spectral karyotyping
• Virtual karyotyping
• Banding Techniques
• G banding
• Q banding
•  R banding
•  C banding
• T banding

 Product

• Instruments
•  Kits and Reagents
• Testing kits
• probes
• Fluorescent affinity reagents
• Others
•  Software and Services
•  Consumables/Accessories

Application

• Oncology
•  Genetic Disorders
• Personalized Medicines
• Others

 End User

• Pharmaceuticals and Biotechnology Companies
• Clinical and Diagnostic Laboratories
• Academic Institutes

Molecular Cytogenetic Market Regional Analysis/Insights

The molecular cytogenetic market is analyzed and market size insights and trends are provided by country, technique, product, application and end user as referenced above.

The countries covered in the molecular cytogenetic market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the molecular cytogenetic market due to the presence of an effective regulatory framework for the regulation of genetic tests along with the strong presence of major entities in this particular region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the advancements in human genetics and disease management, as well as the unrelenting GDP growth of emerging countries such as China and India, are likely to increase consumer purchasing power in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Molecular Cytogenetic Market Share Analysis

The molecular cytogenetic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to molecular cytogenetic market.

Some of the major players operating in the molecular cytogenetic market are:

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Danaher (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Abbott (U.S.)
• Agilent Technologies, Inc. (U.S.)
• PerkinElmer Inc. (U.S.)
• Illumina, Inc. (U.S.)
• Bio-Rad Laboratories, Inc. (U.S.)
• Oxford Gene Technology IP Limited (U.K.)
• Applied Spectral Imaging, Inc. (U.S.)
• Sartorius AG (Germany)
• CytoTest Inc. (U.S.)
• Cytognomix, Inc. (Canada)
• Bionano Genomics (U.S.)
• Precipio (U.S.)
• Leica Biosystems Nussloch GmbH (Germany)

Research Methodology: Global Molecular Cytogenetic Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

SKU-57193